FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention relates to a pharmaceutical composition for treating non-alcoholic fatty liver disease. Disclosed is a pharmaceutical composition for treating non-alcoholic fatty liver disease derived from the following medicinal raw materials: from 26.25 to 180 g of silybin, from 45 to 195 g of soya phospholipid, from 75 to 450 g of Pu'er tea extract, from 15.6 to 226.6 g of L-carnitine or L-carnitine tartrate.
EFFECT: technical result is preventive and therapeutic effect with respect to non-alcoholic fatty liver disease.
18 cl, 1 dwg, 6 tbl, 24 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN, VITAMIN E AND L-CARNITINE | 2016 |
|
RU2700793C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN AND RADIX PUERARIAE EXTRACT | 2016 |
|
RU2697670C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN | 2016 |
|
RU2697523C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN AND VITAMIN E | 2016 |
|
RU2695806C2 |
| PHARMACEUTICAL COMBINATION CONTAINING SILYBIN | 2016 |
|
RU2695224C2 |
| USE OF PEGYLATED RECOMBINANT CHIMERIC MOUSE FIBROBLAST-21 GROWTH FACTOR OR ITS PHARMACEUTICALLY ACCEPTABLE SALT IN COMPOSITION OF DRUGS FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | 2018 |
|
RU2785582C2 |
| PREPARATION, CONTAINING AMINO ACIDS AND PLANTS, AND ITS ACTIVITY IN ALCOHOL DETOXICATION | 2010 |
|
RU2573990C2 |
| BIOCOMPOSITION POSSESSING ANTITOXIC AND ANTI-ADAPTOSIS EFFECT, PROPHYLACTIC BIOLOGICAL SUPPLEMENT BASED ON THEREOF | 2005 |
|
RU2319498C2 |
| APPLICATION OF EXTRACTS OF GINSENG, GYNSENOSIDES AND DERIVATIVES OF GINSENOSIDE FOR THE PREPARATION OF MEDICAL PRODUCTS OR REMEDIES FOR THE TREATMENT OF DISORDERS CAUSED BY CMV | 2016 |
|
RU2679903C1 |
| NEW MILK THISTLE EXTRACT, METHOD FOR PREPARING AND USING IT | 2008 |
|
RU2489161C2 |
